Nicola Baker Selected Research

3-methoxybenzamide

1/2013

An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Baker Research Topics

Disease

4	African Trypanosomiasis (Nagana) 11/2018 - 03/2011
1	Trypanosomiasis 01/2022
1	Neoplasms (Cancer) 04/2015
1	Sepsis (Septicemia) 03/2014
1	Staphylococcal Infections 01/2013

Drug/Important Bio-Agent (IBA)

2	Eflornithine (Ornidyl)FDA Link 11/2018 - 03/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 11/2018
1	Pentamidine (NebuPent)FDA LinkGeneric 03/2013
1	Arsenicals (Arsenic Compounds)IBA 03/2013
1	Melarsoprol (Mel B)IBA 03/2013
1	Succinic Acid (Succinate)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	ProdrugsIBA 01/2013
1	3-methoxybenzamideIBA 01/2013
1	Coloring Agents (Dyes)IBA 01/2012
1	NifurtimoxIBA 03/2011

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 04/2015
1	Early Goal-Directed Therapy 03/2014
1	Therapeutics 03/2011